Chinese Bio-tech Company Dima Bio-technology Raised Tens of Millions of Yuan in an Angle Round Funding

Chinese Bio-tech company Dima Bio-technology raised tens of millions of yuan in an angel round funding by Guoqian Venture Capital, Huatai Zijin Investment, and ETP Fund. The investment will mainly be used on the building of technology platform and project R&D.

Established in August 2019, Dima Bio-technology is a joint venture. It focuses on R&D of   recombinant monoclonal antibodies used in tumor immunity product and service. Boasting a unique RECmAb digital monoclonal antibodies technology, it can acquire multi-species and high quality monoclonal antibodies.